Ocumension Therapeutics (HK:1477) has released an update.
Ocumension Therapeutics has announced changes in its issued share capital, reporting a repurchase and cancellation of 1,960,000 shares, a minor 0.2818% reduction from its previous share count. This financial maneuver was completed in accordance with all applicable regulations and legal requirements, including approval by the board of directors and fulfillment of listing rules and pre-conditions. The company’s closing balance of ordinary shares as of May 21, 2024, stands at 693,654,850 following these transactions.
For further insights into HK:1477 stock, check out TipRanks’ Stock Analysis page.
